TIDMSUN
RNS Number : 2840Z
Surgical Innovations Group PLC
21 May 2021
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
Posting of Annual Report & Accounts
Notice of Annual General Meeting
Surgical Innovations Group plc (AIM: SUN), the designer,
manufacturer and distributor of innovative medical technology for
minimally invasive surgery ("MIS"), confirms that the Annual Report
and Accounts for the year ended 31 December 2020 ("2020 Annual
Report") and the Notice of the 2021 Annual General Meeting ("AGM")
have now been published and can be accessed via the "Investor
Centre" section of the Company's website at: www.sigroupplc.com
The 2020 Annual Report, the Notice of AGM and details voting by
proxy will be posted to shareholders who have not consented to
receive electronic communications.
Notice of AGM
The AGM is to be held on 22 June 2021 at 12:00 noon at the
Company's offices at Clayton Wood House, 6 Clayton Wood Bank,
Leeds, LS16 6QZ and will consider the Resolutions set out in the
Notice of AGM.
Currently, COVID-19 restrictions and guidance are in place which
prevent us convening the AGM in the usual way. The Board are
hopeful that such Government guidance and restrictions may be
relaxed further prior to the AGM, but we will continue to follow
Government guidance. We recognise that the AGM is an important
event for shareholders and the Company is keen to ensure that
shareholders are able to exercise their right to vote and
participate at this year's AGM.
Shareholders wishing to attend the meeting in person should
pre-register their desired attendance by emailing si@surginno.co.uk
, titled 'AGM' no later than 12 noon on Friday 18 June 2021. We
urge individuals to continue to monitor guidance and/or directions
issued by the UK Government on COVID-19 and to act accordingly.
Whilst we currently plan on holding the AGM at our Clayton Wood
House, 6 Clayton Wood Bank, Leeds office in a COVID-19 secure
manner, it is possible that the evolving COVID-19 pandemic and
Government restrictions and guidance in response to any
developments may mean that this is not possible. Accordingly, the
Board strongly encourages Shareholders to vote by proxy on the
resolutions contained in the Notice of AGM.
If it is not possible to attend the AGM this year, we will
provide an opportunity for shareholder engagement prior to the AGM.
In order to facilitate this, if you are a shareholder and would
like to ask the Board a question, please submit your questions to
the following email: si@surginno.co.uk , titled 'AGM'. Shareholders
should note that any questions in relation to confidential or
potentially price sensitive matters will not be addressed, nor will
those for which the answer is already publicly available.
The Board will keep the situation under review and may need to
make further changes to the arrangements relating to the AGM,
including how it is conducted, and Shareholders should therefore
continue to monitor the Company's website for any updated
announcements.
As the AGM will be held as outlined above, you should vote on
the proposed resolutions by appointing a proxy. The proxy
appointment form should be returned, or the electronic proxy
appointment instruction transmitted, no later than 12:00 noon on
Friday 18 June 2021. More details can be found in the Notice of
AGM.
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, Co Sec & GFC
N+1 Singer (Nominated Adviser Tel: 020 7496 3000
& Broker)
Aubrey Powell / Rachel Hayes/
Iqra Amin
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391
303
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part
re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive
against fully disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners, and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
The Group currently employs approximately 100 people across two
sites in the UK. Product design, engineering and manufacturing are
carried out at the SI site in Yorkshire. Commercial activities
including marketing, UK distribution and international sales and
marketing are based at Elemental Healthcare in Berkshire.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www sigroupplc com
www surginno com
www elementalhealthcare co.uk
To receive regular updates by email, please contact
si@walbrookpr.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAAMMPTMTJTMIB
(END) Dow Jones Newswires
May 21, 2021 02:00 ET (06:00 GMT)
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
